Connect
To Top

Meet Patrick Anquetil of Portal Instruments in Kendall Square

Today we’d like to introduce you to Patrick Anquetil.

Thanks for sharing your story with us Patrick. So, let’s start at the beginning and we can move on from there.
I was born and raised in Paris, France and studied engineering at ETH Zurich and MIT.

I arrived at MIT during the golden days of the internet boom and caught the entrepreneurial bug. Following my MBA at Harvard Business School, I went on to start three companies: Aretais, Inc. (blood glucose diagnostic device), SynapDx, Corp. (autism diagnostic test), and Portal Instruments (needle-free drug delivery device).

We’re always bombarded by how great it is to pursue your passion, etc – but we’ve spoken with enough people to know that it’s not always easy. Overall, would you say things have been easy for you?
The life of the entrepreneur is never smooth. There a few great highs who make-up for a lot of lows. You have to be able to manage your own psyche and never let negative thoughts and doubt consume you. That said, I Love it with a capital L. There is nothing else I would want to do. Building is intoxicating: constant action and hustle. Also given our field of medical devices we know that ultimately our efforts will benefit some patient in need.

So, as you know, we’re impressed with Portal Instruments – tell our readers more, for example what you’re most proud of as a company and what sets you apart from others.
At Portal we are developing a novel needle-free drug delivery device that will help patients who need to inject themselves periodically because of a chronic condition. The needle and syringe as we know it has been around for 160 years. It is probably the oldest medical device that is in need of a serious update. Our people is what makes us different, we have some of the most talented folks in the world in their respective fields working with us. Our motto is design, build, test, iterate. We’ve equipped our engineers with state of the art tools and instruments such that we can relentlessly push the envelope to compress the time it takes to develop medical devices while operating in a strongly regulated environment.

So, what’s next? Any big plans?
We are laser focused in bringing our first product to market, which will be a drug delivery device to help patients with chronic conditions who need to self-inject a biologic medicine. Once we’ve launched our first product successfully, the sky becomes the limit in terms of potential applications of our platform technology.

Contact Info:

Getting in touch: BostonVoyager is built on recommendations from the community; it’s how we uncover hidden gems, so if you know someone who deserves recognition please let us know here.

Leave a Reply

Your email address will not be published. Required fields are marked *

More in